Verba Medica - s這wnik medyczny online angielsko - polski, polsko - angielski
  Najwi瘯szy - 96704 hase (48352 polskich, 48352 angielskich)

Archiwum hase

posterior lumbar interbody fusion {PLIF} | neurofibrillary tangles {NFT} | senile plaque | paired helical filaments {PHF} | β -site APP Cleaving Enzyme {BACE} | attention deficit disorder {ADD} | Corticobasal degeneration (CBD)  | Cerebral amyloid angiopathy (CAA) | Hereditary cerebral hemorrhage with amyloidosis {HCHWA} | bovine spongiform encephalitis {BSE} | leukoaraiosis | Mild Cognitive Impairement { | progressive supranuclear palsy {PSP} | retinal ganglion cells {RGCs} | frontotemporal dementia | frontotemporal dementia{FTD} | gelsolin | Hank's balanced salt solution {HBBS} | proportional assist ventilation {PAV} | matrix Gla protein  | Bag-Mask-Ventilation {BMV} | Airway, Breathing, Circulation, Disability, Exposure {ABCDE} | Atrio-Ventricular Nodal Re-entry Tachycardia {AVNRT} | Critical Care Outreach Team {CCOT} | Cardiopulmonary Resuscitation {CPR} | Compression Ventilation ratio {CV} | Unstable Angina Pectoris {UAP} | Supraglottic Airway Device {SAD} | E xtracorporeal Life Support {ECLS} | paramagnetic oxygen analyzer  | High Fructose Corn Syrup {HFSC} | amyotrophic lateral sclerosis and parkinsonism {ALS} | Guam syndrome | neurofibrillary tangles {NFT} | paired helical filaments {PHF} | straight filaments {SF} | twisted filaments {TF} | randomcoiled filaments {RCF} | Retinal ganglion cells {RGC} | quaternary ammonium compounds {QAC} | cellular inhibitor of apoptosis protein 2 {c-IAP2} | cellular FLIP {c-FLIP} | thioredoxin-binding protein {TBP2} | cyclin-dependent kinases {CDKs} | X chromosome-linked inhibitor of apoptosis {XIAP}  | Bain System | degree of methoxylation {DE} | degree of esterification | occupational asthma | galacto-oligosaccharides {GOS} | degree of polymerization {DP} | lingonberry | Safflower  | Echium | sham controlled | transmembrane activator and calcium-modulator and cyclophilin ligand interactor {TACI} | a proliferation inducing ligand {APRIL} | Sea buckthorn | plasma cell labeling index {PCLI} | Network-Extracted Ontology {NeXO} | lupus nephropathy {LN} | inflammatory bowel diseases {IBD} | Wegener's granulomatosis | Sjogren's syndrome {SS} | peripheral blood mononuclear cell {PBMC} | downregulation  | Complementarity determining region {CDR} | skin immune system {SIS} | virus coat protein | hypoxanthine guanine phosphoribosyl transferase {HGPRT} {HPRT} | esophageal adenocarcinoma {EAC} | Primordial Germ Cells {PGC} | Discoid lupus erythematosus (DLE | rapidly progressive glomerular nephritis {RPGN} | IgG4-related disease | disease flare | Dupuytren's flare | Health Assessment Questionnaire {HAQ} | bacteriostatic water for injection {BWFI} | cytotoxic lymphocytes {CTL} | Monoclonal antibodies {mAbs} | Anti-Nuclear Antibodies {ANA} | Bacterial artificial chromosome {BAC} | immunohistochemistry {IHC} | Peanut agglutinin {PNA} | Apple mosaic virus {ApMV} | Arabis mosaic virus {ArMV} | Index of Consciousness {IoC} | positive allosteric modulation {PAM} | sundown syndrome, | dry eye disease {DED} | Meibomian gland | intraocular pressure (IOP) | tear film break-up time (TFBUT) | adeno-associated viruses {AVV} | posttranscriptional gene silencing {PTGS} | cold shock proteins {Csp} | site- directected mutagenesis | site- specific mutagenesis | null mutation | Post-Transcriptional Gene Silencing {PTGS} | Virus Induced Gene Silencing {VIGS} | Helper virus | Continuous positive airway pressure {CPAP} | High-flow nasal cannula {HFNC} | non-invasive positive pressure ventilation {NIPPV} | intermittent positive pressure ventilation {IPPV} | Transcriptional Gene Silencing {TGS} | high-frequency jet ventilation | Sickle-cell anaemia {SCA} | Suppression Subtractive Hybridization {SSH} | colony-forming unit {CFU} | Obstructive sleep apnea {OSA} | Functional Residual Capacity {FRC} | Ventricular rhythm | Non-esterified fatty acids {NEFA} | replication cycle of HCV | direct acting antivirals {DAAs} | Early virological response {EVR} | Host targeting agents {HTAs} | interferon stimulated genes | Rapid virogical response {RVR} | Sustained virological response {SVR} | Untranslated region {UTR} | Japanese encephalitis {JE} | japanese encephalitis virus {JEV} | Scintillation proximity assay {SPA} | central venous catheter {CVC} | Body Temperature Pressure Saturated {BTPS} | chronic heart failure | valvular heart disease | High Altitude Pulmonary Edema {HAPE} | critical limb ischemia | silent myocardial ischemia  | oxidative stress biomarkers | ischemia-reperfusion injury | Neutrophil infiltration  | Dual Anti-platelet Therapy {DAT} | mural thrombus | Neurofibrosarcoma {NFS} | DNA minor groove | histone deacetylase inhibitor | histone deacetylase inhibitor {HDI} | Nuclear export signal {NES} | intratumoral administration {ITu} | Thebesian valve | valve of the coronary sinus | Familial hypobetalipoproteinaemia {(FHBL} | Somatotrophin axis hormones | bone anabolism | alkaline phosphatase isoenzyme | Scarff-Bloom-Richardson grading system {SBR} | triple negative breast cancer {TNBC} | bone turnover marker | Mitral stenosis | cephalgia | Renin angiotensin system {RAS} | Pulmonary arterial hypertension {PAH} | Precapillary pulmonary hypertension | Mean pulmonary artery pressure {MAP} | pulmonary vascular resistance {PVR} | Chronic thromboembolic pulmonary hypertension (CTEPH) | Persistent pulmonary hypertension of the newborn {PPHN} | Pulmonary veno-occlusive disease {PVOD} | Hepatic veno-occlusive disease {VOD} | Pulmonary capillary hemangiomatosis {PCH} | Interstitial lung disease | Myeloproliferative syndromes. | Pulmonary Langerhans' cell histiocytosis {PLCH} | glycogen storage diseases {GSD} | normoxia | chronic hypoxia, | Lysosomal Storage Disorders {LSD} | Very low density lipoproteins {VLDL} | Subacute cutaneous lupus erythematosus {SCLE} | Epigenetics  | Neutrophil Extracellular Trap {NET} | collagen induced arthritis | Murray Valley encephalitis virus {MVEV} | Omsk hemorrhagic fever {OHF} | Anticitrillinated protein antibodies {ACPA} | Neutrophilic dermatoses {ND} | Rapid virological response {RVR} | Direct acting antivirals {DAA} | triple-negative breast cancer {TNBC} | Lipid-based delivery systems (LBDDS} | Self-emulsifying drug delivery systems {SEDDS} | therapeutic index {TI} | Antibody dependent cell mediated cytotoxicity {ADCC} | Complementarity-determining regions {CDR} | Complement-dependent cytotoxicity {CDC} | Receptor activator for nuclear factor kB ligand {RANKL} | Cytotoxic T-lymphocyte antygen 4antygen {CTLA4} | Graft versus host disease {GVHD} | Membrane attack complex {MAC} | Non-acute rejection episode {NONARE} | Complement-dependent cytolysis {CDC} | Bernard-Soulier syndrome {BSS} | Giant platelet syndrome  | Sialidase activity |
Poprzednia    1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56   57   58   59   60   61   62   63   64   65   66   67   68   69   70   71   72   73   74   75   76   77   78   79   80   81   82   83   84   85   86   87   88   89   90   91   92   93   94   95   96   97   98   99   100   101   102   103   104   105   106   107   108   109   110   111   112   113   114   115   116   117   118   119   120   121   122   123   124   125   126   127   128   129   130   131   132   133   134   135   136   137   138   139   140   141   142   143   144   145   146   147   148   149   150   151   152   153   154   155   156   157   158   159   160   161   162   163   164   165   166   167   168   169   170   171   172   173   174   175   176   177   178   179   180   181   182   183   184   185   186   187   188   189   190   191   192   193   194   195   196   197   198   199   200   201   202   203   204   205   206   207   208   209   210   211   212   213   214   215   216   217   218   219   220   221   222   223   224   225   226   227   228   229   230   231   232   233   234   235   236   237   238   239   240   241   242    Nast瘼na
Copyright © 2014 verba-medica.pl. Wszystkie prawa zastrze穎ne. | Regulamin | Polityka prywatno軼i